CTRI/2020/10/028746尚未招募未知
To evaluate the safety and efficacy of Ayurvedic Interventions and Analysis of Gut Flora in the cases of Amavata vis-Ã -vis Rheumatoid Arthritis.
AMRIT GODBOLE0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patients of age group between 30-50 yrs willing to participate for the trial with a diagnosis of rheumatoid arthritis using the ACR 2010.
- •2.Diagnosed cases of Amavata based on symptoms and signs described in Madhav Nidana.
- •3.Patients with H/O more than 1year with established disease.
- •4.Sero positive and Seronegative both cases are included.
排除标准
- •1.Patients not willing to participate.
- •2.Patients with a short history of less than a year.
- •3.Patients having severe deformities.
- •4.Patients of Rheumatic Arthritis, Gouty Arthritis, Infective Arthritis, Osteoarthritis.
- •5.HIV, Tuberculosis, Hypertension, D.M., and other systemic problems.
- •6.Pregnant & lactating women
- •7.Patients with major complications such as extra-articular manifestations are also excluded.
研究者
相似试验
已完成
2 期
Clinical trial of CIM-Meg19 in COVID-19 patientsCTRI/2021/05/033543Ms Meghdoot Gramodyog Sewa Sansthan80
尚未招募
不适用
Evaluation of Role of Ayurvedic Drug- Guduchi Ghan Vati in the treatment of COVID-19 related illnessCTRI/2020/05/025370Dr SR Rajasthan Ayurved University Jodhpur
已完成
3 期
Effect of Ayurveda intervention AYUSH-64 add-on therapy for patients with COVID-19 infection (Stage I)CTRI/2020/05/025156Central Council for Research in Ayurvedic Sciences60
已完成
2 期
Evaluation of Efficacy and Safety of Ayurveda Intervention (Ayush -64) in the management of COVID-19 infection (Asymptomatic &Mild to Moderate symptomsCTRI/2020/05/025338Central Council For Research in Ayurvedic Sciences40
尚未招募
2 期
Study of use of Ayurveda Intervention (Ayush-64) in COVID 19CTRI/2020/06/026002ational Institute of Ayurveda
